Search

everythinglearnresearchcommunity

for

Search:↓

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

A single dose of Platelet Rich Plasma effectively reduces symptoms of early knee osteoarthritis.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

Bempikibart may help regrow hair in people with alopecia areata.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

A new finasteride treatment may quickly and effectively promote hair regrowth.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

The topical finasteride spray was safe and well-tolerated with stable effects.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Alefacept does not effectively treat severe alopecia areata.

The laser treatment improved hair appearance and was safe and well-received by patients.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.